Belimumab shows promise in neuropsychiatric lupus: Another challenge to find the offender

Belimumab shows promise in neuropsychiatric lupus: Another challenge to find the offender

Abstract Introduction Agents that can be used for the treatment of neuropsychiatric lupus (NPSLE) are lacking in the therapeutic armamentarium. Belimumab is a monoclonal antibody targeting the B‐cell activating factor (BAFF) and is approved by the US Food and Drug Administration as an additional tre...

Full description

Bibliographic Details
Main Authors: Shuilian Yu, Zhongjun Hou, Zhiping Liu, Zeying Lin, Ling Zhong, Qilin Yang, Wenhui Huang
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Rheumatology & Autoimmunity
Subjects:
belimumab
lupus nephritis
neuropsychiatric lupus
posterior reversible encephalopathy syndrome
Online Access:https://doi.org/10.1002/rai2.12071

Similar Items

Similar Items